131 related articles for article (PubMed ID: 4566539)
21. Vinblastine treatment of malignant lymphomas.
Klener P; Donner L; Neuwirtová R; Ort J
Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
[No Abstract] [Full Text] [Related]
22. Treatment of the lymphomas.
DeVita VT; Canellos GP
Semin Hematol; 1972 Apr; 9(2):193-209. PubMed ID: 4111886
[No Abstract] [Full Text] [Related]
23. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
24. Splenectomy effects on chemotherapy in Hodgkin's disease.
Panettiere F; Coltman CA
Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
[No Abstract] [Full Text] [Related]
25. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
26. [Direct experience with splenectomy in malignant lymphomas: analysis of 22 cases].
Baccarani M; Lauria F; Capelli A; Bagnara GP; Gugliotta L; Ricci P; Ricci Bitti ML; Staffa GC; Pascucci E; Lodi L; Storti EF; Tura S
G Clin Med; 1971 Feb; 52(2):186-204. PubMed ID: 4943370
[No Abstract] [Full Text] [Related]
27. Combination chemotherapy and survival in advanced Hodgkin's disease.
Canellos GP; Young RC; Berard CW; DeVita VT
Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
[No Abstract] [Full Text] [Related]
28. [Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
Oguro M; Takagi T
Gan To Kagaku Ryoho; 1982 Mar; 9(3):508-15. PubMed ID: 6764108
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
Zarrilli D; Perrone V; Pergola M
Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
[No Abstract] [Full Text] [Related]
30. The indication for chemotherapy in the lymphomas.
Rosenberg SA
Proc Natl Cancer Conf; 1970; 6():83-9. PubMed ID: 5458149
[No Abstract] [Full Text] [Related]
31. [Treatment of malignant lymphoma with Peptichemio. Preliminary communication].
Uszyński L; Maj S; Pawelski S
Acta Haematol Pol; 1974; 5(2):153-7. PubMed ID: 4599294
[No Abstract] [Full Text] [Related]
32. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
33. [Study on antineoplastic chemotherapy of malignant lymphoma and the period of survival, with special reference to lymphatic reticulum cell sarcoma].
Sakai Y
Naika; 1968 Sep; 22(3):651-61. PubMed ID: 4884751
[No Abstract] [Full Text] [Related]
34. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
Wagner K; Haas H; Meyerhold A
Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
[No Abstract] [Full Text] [Related]
35. [Internal medicine aspects of malignant systemic diseases of surgical interest].
Rieche K
Zentralbl Chir; 1976; 101(1):2-7. PubMed ID: 779348
[No Abstract] [Full Text] [Related]
36. [Methylhydrazine in the therapy of malignant lymphopathies].
Beltrametti L; Almici C
Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
[No Abstract] [Full Text] [Related]
37. Current concepts in the management of lymphoma.
Ultmann JE
Proc Inst Med Chic; 1971 Jul; 28(10):421-33. PubMed ID: 4940944
[No Abstract] [Full Text] [Related]
38. [Treatment of Hodgkin's disease with Natulan].
Anglesio E
Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896
[No Abstract] [Full Text] [Related]
39. [Treatment of Waldenström's macroglobulinaemia with procarbazine].
Mitrou P; Schubert JC; Martin H
Dtsch Med Wochenschr; 1972 Dec; 97(48):1864. PubMed ID: 4629116
[No Abstract] [Full Text] [Related]
40. [Action of procarbazine in malignant lymphomas].
Fiorentino M; Finotto E
Presse Med (1893); 1968 Apr; 76(21):992. PubMed ID: 4872010
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
